Results 281 to 290 of about 196,344 (323)
Some of the next articles are maybe not open access.

Stevens-Johnson Syndrome

Archives of Internal Medicine, 1959
This syndrome is characterized by a variation in skin reaction, involvement of the mucous membranes, severe ophthalmia, and a marked general reaction. Stevens and Johnson, in 1922,1described two cases of dramatic onset with fever, conjunctivitis, and a cutaneous eruption, which thereafter has been known as Stevens-Johnson syndrome, or erythema ...
Edward Wasserman, William I. Glass
openaire   +3 more sources

Erythema multiforme, Stevens‐Johnson syndrome/toxic epidermal necrolysis – diagnosis and treatment

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2020
Prior to the first international consensus classification published in 1993, the clinical distinction between erythema multiforme (EM), Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) had been subject to uncertainty and controversy ...
P. Grünwald   +3 more
semanticscholar   +1 more source

Biologic TNF-alpha inhibitors in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a systemic review

Journal of dermatological treatment (Print), 2020
Background: Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN) is one of severe cutaneous adverse reactions with low morbidity but high mortality.
Shan Zhang   +4 more
semanticscholar   +1 more source

Stevens-Johnson Syndrome

Drug Intelligence & Clinical Pharmacy, 1986
Stevens-Johnson syndrome (SJS) is an acute inflammatory eruption of the skin and mucous membranes. Presented here is a case of an 18-month-old child admitted to the hospital with raised erythematous rash with some vesicular formation. The rash and associated symptomatology developed in a manner consistent with SJS.
B G Bryant, B L Mathews
openaire   +3 more sources

Systemic therapies for Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN‐based systematic review and meta‐analysis

Journal of the European Academy of Dermatology and Venereology, 2020
The SCORTEN score is a specific predictor of mortality for patients with Stevens–Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). There is little evidence in support of the common immunomodulating therapies for SJS/TEN.
I. Torres-Navarro   +3 more
semanticscholar   +1 more source

Stevens-Johnson Syndrome

Archives of Dermatology, 1978
To the Editor.— With regards to the brief report, "Permanent Anonychia After Stevens-Johnson Syndrome," in the JulyArchives(113:970, 1977), the authors state that nothing has been written about nail changes in the Stevens-Johnson syndrome. This is not the case.
Jeffrey P. Callen, Joseph J. Chanda
openaire   +3 more sources

Incidence of and mortality from epidermal necrolysis (Stevens–Johnson syndrome/toxic epidermal necrolysis) in France during 2003–16: a four‐source capture–recapture estimate

British Journal of Dermatology, 2020
Because of its rarity, the exact incidence of and mortality from epidermal necrolysis (Stevens–Johnson syndrome/toxic epidermal necrolysis) is difficult to establish and closely depends on the size and type of the data source.
G. Chaby   +11 more
semanticscholar   +1 more source

Stevens‐Johnson syndrome and toxic epidermal necrolysis‐like reactions to checkpoint inhibitors: a systematic review

International Journal of Dermatology, 2020
The use of checkpoint inhibitors for treatment of advanced malignancies is increasing. Rashes, pruritus, and more rarely, reactions resembling Stevens‐Johnsons syndrome (SJS) or toxic epidermal necrolysis (TEN) may occur secondary to checkpoint ...
N. Maloney   +4 more
semanticscholar   +1 more source

Toxic epidermal necrolysis and Stevens‐Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25‐year retrospective study at a single tertiary care center

Pediatric dermatology, 2021
Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis Syndrome (TEN) are rare immune‐mediated diseases. Extensive research on adult triggers of SJS and TEN is available; however, research in children is more limited.
Kristyna L Gleghorn   +2 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy